Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Can develop generics only by referring to an India-approved innovator biologic drug Companies such as Biocon, Panacea Biotec and Avesthagen will now have to follow a fresh set of norms while seeking marketing approval for their biotech products in India. The new norms mandate that companies can develop a biosimilar …
A ban on branded drugs stands to cut 'Big Pharma' out of the $5.4-bn windfall India has put in place a $5.4 billion policy to provide free medicine to its people, a decision that could change the lives of hundreds of millions, but a ban on branded drugs stands to …
New Delhi Stiff opposition from research organisations on how clinical trial victims should be compensated has dealt a blow to health ministry’s efforts to legislate the matter. The ministry was on the brink of making it mandatory for pharmaceutical companies sponsoring clinical trials to pay up financial compensation to volunteers …
Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, have launched a groundbreaking partnership, to expedite the discovery of new treatments for tuberculosis. The partnership, kno wn as the TB Drug Accelerator (TBDA), will target the discovery of new TB drugs by collaborating on …
According to a provision by the Directorate-General of Health Services, Ministry of Health & Family Welfare, every drug, even if marketed internationally, is required to undergo a clinical trial in India before approval for release in the market. Re-trials of all such drugs are bound to pose problems of increased …
JAIPUR: With the launch of Janani Shishu Suraksha Yojna (JSSY), the state government has succeeded in increasing the number of institutional deliveries.The state government figure shows, since the launch of JSSY in September 2011 , the state government has registered over 5.30 lakh institutional deliveries upto May 25, 2012. Rajasthan …
Govt Effort To Promote Generics Has Failed New Delhi: The Delhi Government’s attempt to curb overuse of antibiotics and promote generic drugs in hospitals has failed to enthuse doctors. A sample study was conducted on prescription trends at the state-run Deen Dayal Upadhyaya (DDU) Hospital and it has shown that …
JAIPUR: The medical health and family welfare department is in the process of framing rules for effective implementation of the Clinical Establishment Act 2010, which was passed in the Vidhan Sabha last year. A medical health and family welfare department official said, "We have started working on implementation of the …
MUMBAI, 24 JUNE: Multi-national pharmaceutical companies have increased their focus on the country following their rapid growth in the Indian market. “After under-performing for several years, pharmaceuticals MNCs have outperformed the industry growth in calendar year 2011,” rating agency Icra said in its report titled 'Indian Pharmaceutical Industry: Trends & …
The Central Drugs Standard Control Organisation is expected to protect the citizen from the marketing of harmful pharmaceuticals. The fi ndings of the 59th report of the Parliamentary Standing Committee on Health and Family Welfare are an expose of the shockingly lax standards followed by this so-called standards organisation, the …
This move could cost $299 million a year for Indian pharma players All generic pharmaceutical companies, including Ranbaxy Laboratories, Cipla, Dr Reddy’s Laboratories, Lupin, Glenmark and Torrent Pharma, might soon have to pay a fee to the US drug regulator when they seek its permission to sell their products there. …
NEW DELHI, 20 JUNE: The ministry of health & family welfare has issued a gazette notification under the Drugs and Cosmetics Act banning the manufacture and sale as well as the import of serological test kits to detect tuberculosis (TB). The notification was issued on 7 June. The serological (blood …
Leading pharma companies including GlaxoSmithkline, Pfizer and Ranbaxy sell commonly used drugs at a rate 10 times the cost of production, a study by the Corporate Affairs Ministry has found. A study by the Cost Audit branch of the MCA found drugs like Calpol manufactured by Glaxosmithkline, Corex Cough Syrup …
Move aimed at ending regulatory uncertainty that is holding up clearances of proposals KHOMBA SINGH NEW DELHI The government has formed an inter-ministerial panel for finalising guidelines for allowing MNCs to buy equity stakes in Indian drug companies, as it seeks to end the regulatory uncertainty that is holding up …
The government has initiated a process to reduce Indian drug industry’s growing dependence on China for raw materials, including the critical penicillin, which is needed to manufacture most of the anti-infective drugs. An industry executive told ET that the Organisation of Pharmaceutical Producers of India (OPPI) has submitted a list …
The World Health Organisation (WHO) has put in place a mechanism to define counterfeit medical products. The set of definitions of sub-standard, spurious, falsely labelled, falsified and counterfeit products will be globally accepted and help to bring about uniformity in identifying such drugs, without interrupting worldwide supplies. The decision to …
The Union Ministry of Health and Family Welfare is considering creation of National Commission for Human Resource in Health (NCHRH), an over arching regulatory body for the health sector, with the twin objective of reforming the current regulatory framework and enhancing the supply of skilled personnel. This has been stated …
The Madras High Court has upheld the validity of a notification issued by the Union Ministry of Health and Family Welfare on March 16 last year banning the manufacture, sale and distribution of Gatifloxacin, a drug used for treating acute bacterial exacerbation of chronic bronchitis, acute sinusitis and community acquired …
